Dr. M. Elaine Husni is Vice Chair, and Director, Arthritis and Musculoskeletal Center in the Orthopedic and Rheumatologic Institute at the Cleveland Clinic. She is currently Director of Clinical Outcomes research. Dr. Husni is an assistant professor at the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University. She trained in Rheumatology at the Brigham and Women's Hospital at Harvard Medical School and received her MD and MPH degrees from Boston University School of Medicine.
Dr. Husni's most recent research focus is examining cardiovascular (CV) outcomes of patients with psoriasis, and psoriatic arthritis. Her work focuses on potential mechanism of accelerated CV disease in these patients by examining proatherogenic or inflammatory lipids and biomarkers as well as novel therapeutics for psoriatic diseases.
She is also involved in a number of rheumatology clinical trials at the Cleveland Clinic focusing on osteoarthritis, psoriatic arthritis, and rheumatoid arthritis including the PRECISION trial. This trial focuses on the cardiovascular risks associated among 3 common NSAIDs – ibuprofen, naproxen, and celecoxib. She is a past recipient of the Physician Scientist Development Award and Clinical Investigator Award by the American College of Rheumatology for her research and funded by the National Psoriasis Foundation. Her research is also funded by an NIH RO1 grant.
Friday, November 6, 2020
4:00 PM – 5:00 PM ET
Sunday, November 8, 2020
9:00 AM – 11:00 AM ET